Clinical Trial Update: Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection [Phase 2]

View source ↗

Summary

Phase 2 trial update for Ziv-aflibercept in ocular diseases requiring anti-VEGF injections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Choroidal Neovascularization
• Cystoid Macular Edema
• Diabetic Retinopathy
• Neovascularization
• Pterygium
• Retinal Neovascularization
• Retinal Vein Occlusion

Drugs mentioned

• Ziv-aflibercept (ziv-aflibercept)

Snippet

Sponsor: Rafic Hariri University Hospital | Conditions: Neovascularization, Macular Degeneration | Phase 2 | Status: UNKNOWN